The pooled effect size indicated a potential reduction in the incidence of newly developed asthma among patients with type 2 diabetes who used metformin, although this finding did not reach statistical significance.
← all excerpts
Association of metformin use with asthma development and adverse outcomes: A systematic review and meta-analysis.
1
—
—